Retorna Facial Cream in the Treatment of Facial Wrinkles

Status Completed

Clinical Trial Summary

The purpose of the study is to assess the efficacy of Retorna facial cream usage in the reduction or total correction of facial wrinkles. The duration of this double-blind placebo controlled phase 3 clinical trial will be 4 weeks. The estimated number of women to be recruited and randomized for the study is 148. Occurrence of adverse effects will also be evaluated.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00978887
Study type	Interventional
Source	Catalysis SL
Contact
Status	Completed
Phase	Phase 3
Start date	October 2009
Completion date	May 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01447342` - A Study to Evaluate the Safety and Effectiveness of the Cryo-Touch II Device for the Treatment of Forehead and/or Glabellar Lines	Phase 2/Phase 3
Completed	`NCT00414544` - Evaluation of the Safety and Efficacy of CosmetaLife™ for the Correction of Nasolabial Folds	Phase 2
Completed	`NCT00888914` - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines	Phase 2
Completed	`NCT00877279` - Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft	Phase 3
Completed	`NCT01124565` - Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults	Phase 2
Completed	`NCT00922623` - Safety and Effectiveness of Belotero® in Subjects With Fitzpatrick Phototypes IV Through VI	N/A
Not yet recruiting	`NCT03836638` - The Impact of Age on Botulinum Toxin Potency in Facial Rhytides Treatment	N/A
Not yet recruiting	`NCT06322875` - A Clinical Study to Evaluate the Efficacy and Satisfaction of RHC Serum Combined With RHC(III) Injection	N/A
Completed	`NCT01566396` - Evaluation of Safety and Efficacy of the 3F Applicator (A3F) for Treatment of Facial Wrinkles	N/A
Completed	`NCT01151436` - Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers	N/A
Completed	`NCT06321770` - Oral Supplementation With Active Collagen Peptides and Skin Health Improvement	N/A
Completed	`NCT01379365` - Cryo-Touch III Refinement Study Investigational Plan	Phase 2/Phase 3
Completed	`NCT00288470` - A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast.	N/A
Completed	`NCT02122536` - Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles	N/A
Completed	`NCT01167140` - Cryo-Touch II for the Treatment of Wrinkles	Phase 2/Phase 3
Completed	`NCT00968825` - Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines	Phase 2
Completed	`NCT03286283` - The Use of J-Plasma® for Dermal Resurfacing	N/A
Completed	`NCT01064518` - Efficacy and Safety Study of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults	Phase 2
Completed	`NCT00417469` - A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)	Phase 3
Completed	`NCT00293163` - A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.	Phase 4